A diverse collaborative of organizations and individuals that promotes and implements precautionary action to protect health and the environment. Works for fundamental changes in decision making that build healthier, more just, and sustainable communities, and serves as a resource and catalyst that works locally, regionally, and beyond to promote the precautionary principle through education and outreach, public mobilization, grassroots participation, and policy reform.
Mythe : la publicité s’adressant directement au consommateur permet d’informer le patient
Media Type:
Online
Discusses and debunks the idea promoted by drug companies that direct-to-consumer advertising of prescription drugs has health benefits for patients. Discusses the risks for patients being prescribed unnecessary drugs, and the astronomical costs that legalizing DTCA in Canada could entail.
Powerpoint presentation on some of the work of Women and Health Protection, including research into the effects of Direct-to-Consumer Advertising (DTCA) of prescrption drugs, the CanWest Charter Challenge, a public forum on silicone gel breast implants, and women and statins.
Society of Obstetricians and Gynecologists of Canada
Discusses how Canada’s obstetrics and gynecology society is proposing a national birthing strategy to help address a shortage of maternity healthcare professionals – and a looming maternity care crisis.
British Columbia Centre of Excellence for Women's Health (BCCEWH)
Media Type:
Paper
Author:
Ann Pederson
Aleina Tweed
Discusses the challenges of understanding the effects of breast implants and breast implant surgery. Proposes the establishment of a breast implant registry to collect information about this medical device and its use in Canada.
Presents the proceedings of a symposium that examined women and the pharmaceuticals industry. Includes presentations of the three panellists and a brief summary of each of the workshops.
Works to build and sustain a Canada-wide movement that will generate the resolve and the actions required to eliminate the preventable causes of cancer.
Argues that the federal government is protecting drug companies instead of the public by keeping information about the drug approval process secret. Examines the impact of this on women's health.
Argues that the lack of transparency in the drug approval process can lead to inappropriate, unnecessary and sometimes dangerous drug use, and it impedes the development of knowledge and appropriate decision-making.
Looks at the impact of SSRI use among Canadian women. Reviews what is currently known about the benefits and harms caused by SSRIs, as well as both the definition and incidence of depression in women.
